BCL-Xl Is Qualitatively Different From and Ten Times More Effective Than BCL-2 When Expressed in a Breast Cancer Cell Line

BMC Cancer - United Kingdom
doi 10.1186/1471-2407-6-213
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC


Related search